A92

Q3 Medicine
M. Mukhacheva, B. Beyn
{"title":"A92","authors":"M. Mukhacheva,&nbsp;B. Beyn","doi":"10.1016/j.ejcsup.2015.08.068","DOIUrl":null,"url":null,"abstract":"<div><p>This work is devoted to the actual problem of studying modern ideas about the systemic treatment of brain tumors, in particular on the implementation and effectiveness of modern methods of immunomodulation in neuro-oncology. The aim is to clarify the existence of patients with brain tumors immunosuppression, resulting in testimony to the development and application of methods of immunotherapy. Method of research consistent with the goal and objectives of the study, which included a dynamic examination of 32 operated patients with hemispheric brain gliomas. Cycloferon interferonogens from the group, which has antiviral and antitumor action potential was used as an immunomodulator us. It is of interest to determine the effectiveness of immunomodulatory action of cycloferon in patients with brain tumors in different phases of development of cancer. This work represents a scientific novelty and practical significance for solving urgent problems of neurology and neurosurgery – the study of the cycloferon drug, has proved its effectiveness in the reinforcement of clinical remission and increased the life expectancy of patients with brain tumors after surgery.</p></div>","PeriodicalId":11675,"journal":{"name":"Ejc Supplements","volume":"13 1","pages":"Pages 38-39"},"PeriodicalIF":0.0000,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejcsup.2015.08.068","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejc Supplements","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1359634915000695","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

This work is devoted to the actual problem of studying modern ideas about the systemic treatment of brain tumors, in particular on the implementation and effectiveness of modern methods of immunomodulation in neuro-oncology. The aim is to clarify the existence of patients with brain tumors immunosuppression, resulting in testimony to the development and application of methods of immunotherapy. Method of research consistent with the goal and objectives of the study, which included a dynamic examination of 32 operated patients with hemispheric brain gliomas. Cycloferon interferonogens from the group, which has antiviral and antitumor action potential was used as an immunomodulator us. It is of interest to determine the effectiveness of immunomodulatory action of cycloferon in patients with brain tumors in different phases of development of cancer. This work represents a scientific novelty and practical significance for solving urgent problems of neurology and neurosurgery – the study of the cycloferon drug, has proved its effectiveness in the reinforcement of clinical remission and increased the life expectancy of patients with brain tumors after surgery.

A92
这项工作致力于研究关于脑肿瘤全身治疗的现代思想的实际问题,特别是关于神经肿瘤学中现代免疫调节方法的实施和有效性。目的是阐明脑肿瘤患者免疫抑制的存在,从而为免疫治疗方法的发展和应用提供证据。研究方法符合研究的目的和目的,包括对32例半球脑胶质瘤手术患者进行动态检查。具有抗病毒和抗肿瘤作用的环铁干扰素被用作免疫调节剂。研究环铁素对处于不同发展阶段的脑肿瘤患者免疫调节作用的有效性具有重要意义。本工作对于解决神经病学和神经外科亟待解决的问题具有科学的新颖性和现实意义——环铁龙药物的研究,已证明其在加强临床缓解和提高脑肿瘤患者术后预期寿命方面的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ejc Supplements
Ejc Supplements 医学-肿瘤学
自引率
0.00%
发文量
0
审稿时长
3.7 months
期刊介绍: EJC Supplements is an open access companion journal to the European Journal of Cancer. As an open access journal, all published articles are subject to an Article Publication Fee. Immediately upon publication, all articles in EJC Supplements are made openly available through the journal''s websites. EJC Supplements will consider for publication the proceedings of scientific symposia, commissioned thematic issues, and collections of invited articles on preclinical and basic cancer research, translational oncology, clinical oncology and cancer epidemiology and prevention. Authors considering the publication of a supplement in EJC Supplements are requested to contact the Editorial Office of the EJC to discuss their proposal with the Editor-in-Chief. EJC Supplements is an official journal of the European Organisation for Research and Treatment of Cancer (EORTC), the European CanCer Organisation (ECCO) and the European Society of Mastology (EUSOMA).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信